688166 博瑞醫藥
按盤價 
34.500 +4.880 (+16.475%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.473 | 8.880 | 12.384 | 15.688 | 12.380 |
| 總資產報酬率 ROA (%) | 2.073 | 4.178 | 6.280 | 10.170 | 10.457 |
| 投入資產回報率 ROIC (%) | 2.218 | 4.503 | 6.910 | 11.259 | 9.897 | 邊際利潤分析 |
| 銷售毛利率 (%) | 55.295 | 55.794 | 63.011 | 56.227 | 54.927 |
| 營業利潤率 (%) | 14.353 | 16.129 | 23.803 | 24.609 | 24.582 |
| 息稅前利潤/營業總收入 (%) | 17.207 | 18.051 | 24.771 | 25.009 | 24.960 |
| 淨利潤/營業總收入 (%) | 12.502 | 14.703 | 20.783 | 22.573 | 21.564 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 109.723 | 105.522 | 96.612 | 102.124 | 97.730 |
| 價值變動淨收益/利潤總額(%) | -8.640 | -8.084 | 0.232 | 3.892 | 1.877 |
| 營業外收支淨額/利潤總額(%) | -0.096 | -0.781 | 0.021 | -0.597 | -0.911 | 償債能力分析 |
| 流動比率 (X) | 1.715 | 1.995 | 2.388 | 1.703 | 3.244 |
| 速動比率 (X) | 1.389 | 1.621 | 2.043 | 1.360 | 2.548 |
| 資產負債率 (%) | 53.846 | 51.954 | 51.908 | 41.351 | 21.623 |
| 帶息債務/全部投入資本 (%) | 49.372 | 47.836 | 48.341 | 35.207 | -- |
| 股東權益/帶息債務 (%) | 98.670 | 105.609 | 105.323 | 181.201 | 584.603 |
| 股東權益/負債合計 (%) | 84.773 | 90.604 | 90.579 | 136.663 | 362.266 |
| 利息保障倍數 (X) | 5.999 | 8.820 | 25.716 | 45.853 | 41.597 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 82.307 | 89.395 | 119.636 | 94.175 | 0.000 |
| 存貨周轉天數 (天) | 206.589 | 215.752 | 229.802 | 157.568 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
